Pharmaceutical applications for methanediphosphonate derivative
AssigneeToray Industries, Inc.
InventorsNorio Kawabe, Hiromi Uchiro, Teruo Nakadate, Masahiko Tanahashi, Masatoshi Ito
Life of this patent
Estimating the term…
Loading patent…
AssigneeToray Industries, Inc.
InventorsNorio Kawabe, Hiromi Uchiro, Teruo Nakadate, Masahiko Tanahashi, Masatoshi Ito
Estimating the term…
The present invention relates to a methanediphosphonate derivative, its manufacturing process, and pharmaceutical applications, that is represented with the following formula: ##STR1## wherein, D is either sulfur, oxygen, NH, alkyl-substituted N, CH.sub.2, or SCH.sub.2, X represents an alkyl group, alkyl group having a hetero atom as a substitution group, an aryl group or an acyl group, m represents an integer of 1 to 5, and R.sup.1, R.sup.2, R.sup.3 and R.sup.4 independently represent hydrogen, alkyl groups having 1 to carbon atoms or pharmaceutically allowable cations. .function.The compounds of the present invention have excellent IL-1 inhibitory action, antioxidation action and bone resorption inhibitory action, and are useful as antiinflammatory agents, antirheumatic agents, bone metabolic disease drugs, autoimmune disease drugs, or osteoporosis drugs.
A method of treating diseases selected from the group consisting of rheumatism and bone metabolic disease, and for inhibiting patient physiological conditions selected from the group consisting of inflammation, interleukin-1 production, interleukin-1-induced cellular response, active oxygen production in neutrophils and bone resorption, comprising administering an effective amount of a methanediphosphonate derivative represented by formula (I):
Dependencies are inferred from the claim text.